Blonanserin vs risperidone in Japanese patients with schizophrenia: A post hoc analysis of a phase 3, 8‐week, multicenter, double‐blind, randomized controlled study

OBJECTIVE: To report the efficacy and safety of blonanserin in patients with schizophrenia compared with risperidone in a Japanese multicenter, randomized, double‐blind study based on post hoc sensitivity analysis in addition to the previous results reported by Miura and discuss the current approach...

Descripción completa

Detalles Bibliográficos
Autores principales: Harvey, Philip D., Nakamura, Hiroshi, Miura, Sadanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292214/
https://www.ncbi.nlm.nih.gov/pubmed/31788985
http://dx.doi.org/10.1002/npr2.12089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292214/
https://www.ncbi.nlm.nih.gov/pubmed/31788985
http://dx.doi.org/10.1002/npr2.12089

Ejemplares similares